Abstract Details
Clementine Karageorgiou, MD (Neurological Institute of Athens) | The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR. |
Ioanna Chatzi | No disclosure on file |
No disclosure on file | |
Athanasia Alexoudi, MD | No disclosure on file |
No disclosure on file | |
Baki Goksan, PhD | No disclosure on file |
No disclosure on file | |
Elissaios Karageorgiou, MD, PhD, FAAN (Neurological Institute of Athens) | Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union. |
Eleni Papageorgiou | No disclosure on file |
Giorgos Tagaris | No disclosure on file |
No disclosure on file |